Share
Print
Non-Genotoxic Carcinogenesis
Details
Location:EU 27
Funding agency:
Grantmaking entity type:Development Institution
Description
Programme(s): FP7-JTI - Specific Programme "Cooperation": Joint Technology Initiatives
Topic(s): IMI-JU-01-2008-02 - Non-Genotoxic Carcinogenesis
Call for proposal: IMI-JU-01-2008
Funding Scheme: JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)
Similar grants
By Locations
Funding agency:
Horizon Europe
Status:
awarded
Location:
EU 27
Funding agency:
EC
Status:
awarded
Location:
EU 27
By Sectors
Funding agency:
Gates Foundation
Status:
awarded
Location:
Afghanistan, Albania, Algeria, American Samoa, Angola, Argentina, Armenia, Azerbaijan, Bangladesh, Belarus, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Cape Verde, Central African Republic, Chad, China, Colombia, Comoros, Congo, Costa Rica, Cote d'Ivoire, Cuba, Dem. Rep. Congo, Djibouti, Dominica, Commonwealth of, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Eswatini (Swaziland), Ethiopia, Fiji, Gabon, Gambia, Georgia, Ghana, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, India, Indonesia, Iran, Iraq, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Kosovo, Kyrgyzstan, Laos, Lebanon, Lesotho, Liberia, Libya, Madagascar, Malawi, Malaysia, Maldives, Mali, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia, Moldova, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Nicaragua, Niger, Nigeria, North Korea, North Macedonia, Pakistan, Palestine / West Bank & Gaza, Papua New Guinea, Paraguay, Peru, Philippines, Romania, Russia, Rwanda, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Sao Tome and Principe, Senegal, Serbia, Sierra Leone, Solomon Islands, Somalia, South Africa, South Sudan, Sri Lanka, Sudan, Suriname, Syria, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Tunisia, Turkey, Turkmenistan, Tuvalu, Uganda, Ukraine, Uzbekistan, Vanuatu, Venezuela, Vietnam, Yemen, Zambia, Zimbabwe
Funding agency:
Horizon Europe
Status:
awarded
Location:
EU 27
grant Background
About the Funding Agency
The European Union's Framework 7 Programme (FP7) for research financing expired in 2014 to be replaced by the new Horizon 2020 program which is the financial instrument used to establish Innovation Union, a flagship program of Europe 2020 that aims to ensure Europe's worldwide competitiveness.
Horizon 2020 is intended to be a tool to stimulate economic growth and create employment and enjoys the political support of Europe's leaders and Members of the European Parliament.
Horizon 2020 contributes to this goal by tying research and innovation together and concentrating on three critical areas: outstanding science, industrial leadership and societal issues. The objective is for Europe to create world-class research and technology which will drive economic growth.
Furthermore, the program concentrates its efforts on fewer issues with larger resources therefore directly supporting the Commission's political goals. It works to build a low-carbon, a climate-resilient future, connect economic and environmental advantages, develop a the circular economy and digitize and modernize European industry and services to increase effectiveness.
About the Sectors
Health
Covers healthcare services, public health systems, and activities aimed at promoting physical and mental well-being.
Key areas:
- Healthcare services and facilities
- Public health and disease prevention
- Medical equipment, supplies, and services
Research & Innovation
Focuses on collecting data, generating new knowledge, and applying it to develop improved methods, technologies, products, and solutions across sectors.
Key areas:
- Scientific research, studies, and investigations
- Innovation programs and applied R&D initiatives
- Technology development
- Space-related research and exploration themes